Search

Your search keyword '"Warnecke, G"' showing total 1,626 results

Search Constraints

Start Over You searched for: Author "Warnecke, G" Remove constraint Author: "Warnecke, G"
1,626 results on '"Warnecke, G"'

Search Results

251. Are Donors with Pulmonary Arterial Embolism the Better Donors for Lung Transplantation?

254. Donor Endothelial Inflammation and Recipient Leukocytes Contribute Independently to Primary Graft Dysfunction in Lung Transplant Recipients - Insights from a Humanized Mouse Model

257. Increasing Frequency of CD127 low Regulatory T Cells Early After Lung Transplantation Is Associated with Freedom from Chronic Lung Allograft Rejection and Survival in 503 Patients

261. Telemonitoring in LVAD-Patients: Acceptance and Need

262. Risk Factors for Intraoperative Extracorporeal Circulatory Support in Patients Undergoing Lung Transplantation for Pulmonary Fibrosis

263. Three Years Experience with an IgM Enriched Human Intravenous Immunoglobulins Based Treatment for Patients with Early Donor Specific Antibodies After Lung Transplantation

264. Lung Donation After Drowning

266. Autotransplantation of the Left Lung for the Treatment of Recurrent Life Threatening Pulmonary Hemorrhage Related to Pulmonary Vascular Malformation: A Novel Treatment Approach & a Unique Chance to Study Ischemia/Reperfusion Injury

267. Similar molecular subtypes of lung injury patterns in interstitial lung disease, stem cell and lung transplantation

272. The Impact of Telemonitoring in Patients with Ventricular Assist Device

275. Cytokine Expression in Humanized Mice Reflects Development of Primary Graft Dysfunction in Lung Transplant Recipients

276. Three Years of Experience with an IgM-Enriched Human Intravenous Immunoglobulin-Based Treatment for Patients with Early Donor-Specific Anti-HLA Antibodies after Lung Transplantation

277. In Vivo Development of Transplant Arteriosclerosis in Humanized Mice Reflects BOS in Lung Transplant Recipients and Is Controlled by Autologous Regulatory T Cells

278. Risk assessment of inhalable read-across chemicals with different mode of action showed great differences in cytotoxicity in rat and human precision-cut lung slices

281. Mid and Long-Term Clinical Results of OCS Lung INSPIRE International Trial

282. Impact of OCS Lung Portable EVLP on Pulmonary Function and Bronchiolitis Obliterans in Standard Lung Transplant Recipients - Prospective Evidence from the OCS Lung INSPIRE Trial Patients

283. Early Donor Specific Antibodies Correlate with a Distinct Peripheral Cellular Immune Phenotype after Lung Transplantation

284. ‘Unacceptable’ Human Leukocyte Antigens in Lung Re-Transplantation

285. Lung First vs. Liver First Sequence for Combined Lung and Liver Transplantation

286. Lung Transplantation and Concomitant Treatment of Significant Coronary Artery Disease: Insights from a Single-Center Experience

287. Leukocytes Transfer More Severe Rejection from Lung Transplant Recipients with Severe PGD into Humanized Mice and Are Sensitive to T Cell Regulation

290. The OCS Lung EXPAND International Trial Interim Results

292. Heart-Lung Transplantation for Congenital Heart Disease: A 25 Years Single Center Experience

295. Evolving Risk Factors for Mortality after Lung Transplantation over the Last 10 Years: Insights from a Single-Centre Database

296. IgM Enriched Human Immunoglobulins and Rituximab Nullify the Mortality Risk Associated with Early Donor Specific Antibodies After Lung Transplantation

297. Risk Factors and Impact of Bronchial Stenoses after Lung Transplantation: Ten Year Single Center Experience with over 1,100 Patients

298. T1-Mapping zur Beurteilung von Nierenschäden nach Organtransplantation

Catalog

Books, media, physical & digital resources